The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Anderman Jonathan | General Counsel | Buy(P) | 25K | $1.89 | $47K |
| Apr 29, 2026 | Lerner Neil | Chief Accounting Officer | Buy(P) | 15K | $1.89 | $28K |
| Feb 8, 2026 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 37K | $6.52 | $239K |
| Jan 9, 2026 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 47K | $5.35 | $250K |
| Jan 2, 2026 | Anderman Jonathan | General Counsel | Grant(A) | 150K | $5.17 | $776K |
| Jan 2, 2026 | Anderman Jonathan | General Counsel | Grant(A) | 720K | — | $0 |
| Jan 2, 2026 | Ferneau Philip | Director | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Gordon Carl L | Director | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Boylan James P | Director | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Gray Mary Ann | Director | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Lerner Neil | Chief Accounting Officer | Grant(A) | 63K | $5.17 | $323K |
| Jan 2, 2026 | Lerner Neil | Chief Accounting Officer | Grant(A) | 435K | — | $0 |
| Jan 2, 2026 | Chiniara Ellen | Director | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Lindahl Richard S | Director | Grant(A) | 90K | — | $0 |
| Jan 2, 2026 | Prasad Arjun | Chief Commercial Officer | Grant(A) | 1.0M | — | $0 |
| Jan 2, 2026 | Schuetz Thomas J. | CEO, Director | Grant(A) | 250K | $5.17 | $1.3M |
| Jan 2, 2026 | Schuetz Thomas J. | CEO, Director | Grant(A) | 2.0M | — | $0 |
| Jan 2, 2026 | Sirard Cynthia | Chief Medical Officer | Grant(A) | 1.0M | — | $0 |
| Jan 2, 2026 | Shin Barry | CFO | Grant(A) | 125K | $5.17 | $646K |
| Jan 2, 2026 | Shin Barry | CFO | Grant(A) | 670K | — | $0 |
| Nov 16, 2025 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 44K | $4.83 | $213K |
| May 27, 2025 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 10K | $2.11 | $21K |
| Apr 9, 2025 | OrbiMed Capital GP VI LLC | Director, 10% Owner | Sell(S) | 3.6M | $1.59 | $5.7M |
| Apr 9, 2025 | Gordon Carl L | Director, 10% Owner | Sell(S) | 3.6M | $1.59 | $5.7M |
| Apr 7, 2025 | Lerner Neil | CHIEF ACCOUNTING OFFICER | Buy(P) | 20K | $1.42 | $28K |
| Apr 7, 2025 | Anderman Jonathan | Gen Counsel & Corporate Sec | Buy(P) | 20K | $1.54 | $31K |
| Feb 11, 2025 | Boylan James P | Director | Grant(A) | 40K | — | $0 |
| Feb 11, 2025 | Gordon Carl L | Director, 10% Owner | Grant(A) | 40K | — | $0 |
| Feb 11, 2025 | Anderman Jonathan | Sr VP, Gen Counsel & Corp Sec | Grant(A) | 280K | — | $0 |
| Feb 11, 2025 | Chiniara Ellen | Director | Grant(A) | 40K | — | $0 |
| Feb 11, 2025 | Ferneau Philip | Director | Grant(A) | 40K | — | $0 |
| Feb 11, 2025 | Gray Mary Ann | Director | Grant(A) | 40K | — | $0 |
| Feb 11, 2025 | Lerner Neil | SVP, CAO | Grant(A) | 200K | — | $0 |
| Feb 11, 2025 | Lindahl Richard S | Director | Grant(A) | 40K | — | $0 |
| Feb 11, 2025 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 1.5M | — | $0 |
| Feb 11, 2025 | Shin Barry | CFO | Grant(A) | 250K | — | $0 |
| Feb 8, 2025 | Schuetz Thomas J. | CEO, Director | Tax withholding(F) | 42K | $3.50 | $146K |
| Jan 9, 2025 | Schuetz Thomas J. | CEO, Director | Tax withholding(F) | 58K | $1.86 | $108K |
| Dec 9, 2024 | Shin Barry | CFO | Grant(A) | 400K | $1.65 | $660K |
| Dec 9, 2024 | Shin Barry | CFO | Grant(A) | 400K | — | $0 |
| Aug 13, 2024 | Anderman Jonathan | Sr VP, Gen Counsel & Corp Sec | Grant(A) | 300K | — | $0 |
| Mar 8, 2024 | Boylan James P | Director | Grant(A) | 40K | — | $0 |
| Feb 9, 2024 | Ferneau Philip | Director | Grant(A) | 40K | — | $0 |
| Feb 9, 2024 | Chiniara Ellen | Director | Grant(A) | 40K | — | $0 |
| Feb 9, 2024 | Gordon Carl L | Director, 10% Owner | Grant(A) | 40K | — | $0 |
| Feb 9, 2024 | Lindahl Richard S | Director | Grant(A) | 40K | — | $0 |
| Feb 9, 2024 | Gray Mary Ann | Director | Grant(A) | 40K | — | $0 |
| Feb 8, 2024 | Schuetz Thomas J. | PRESIDENT, Director | Tax withholding(F) | 45K | $1.45 | $65K |
| Feb 8, 2024 | Bisker-Leib Vered | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 49K | $1.45 | $71K |
| Jan 9, 2024 | Schuetz Thomas J. | President of R&D, Director | Grant(A) | 638K | $1.93 | $1.2M |
| Jan 9, 2024 | Schuetz Thomas J. | President of R&D, Director | Grant(A) | 638K | — | $0 |
| Jan 9, 2024 | Bisker-Leib Vered | Chief Executive Officer, Director | Grant(A) | 1.8M | $1.93 | $3.4M |
| Jan 9, 2024 | Bisker-Leib Vered | Chief Executive Officer, Director | Grant(A) | 1.8M | — | $0 |
| Nov 17, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 44K | $1.50 | $66K |
| Nov 17, 2023 | Bisker-Leib Vered | Chief Operating Officer | Tax withholding(F) | 64K | $1.50 | $97K |
| Apr 21, 2023 | Lindahl Richard S | Director | Grant(A) | 50K | — | $0 |
| Mar 10, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 10K | $3.37 | $34K |
| Feb 27, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $3.98 | $80K |
| Feb 15, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $3.86 | $77K |
| Feb 8, 2023 | Bisker-Leib Vered | Chief Operating Officer | Grant(A) | 400K | — | $0 |
| Feb 8, 2023 | Bisker-Leib Vered | Chief Operating Officer | Grant(A) | 600K | — | $0 |
| Feb 8, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 500K | — | $0 |
| Feb 8, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 700K | — | $0 |
| Feb 8, 2023 | Gordon Carl L | Director, 10% Owner | Grant(A) | 60K | — | $0 |
| Feb 8, 2023 | Ferneau Philip | Director | Grant(A) | 50K | — | $0 |
| Feb 8, 2023 | Gray Mary Ann | Director | Grant(A) | 40K | — | $0 |
| Feb 8, 2023 | Chiniara Ellen | Director | Grant(A) | 40K | — | $0 |
| Feb 8, 2023 | Wurzer David M | Director | Grant(A) | 50K | — | $0 |
| Jan 31, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $4.05 | $81K |
| Jan 24, 2023 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $4.19 | $84K |
| Nov 25, 2022 | Bisker-Leib Vered | Chief Operating Officer | Sell(S) | 2 | $4.36 | $9 |
| Nov 23, 2022 | Bisker-Leib Vered | Chief Operating Officer | Sell(S) | 10K | $4.30 | $41K |
| Nov 22, 2022 | Bisker-Leib Vered | Chief Operating Officer | Sell(S) | 15K | $4.19 | $63K |
| Nov 21, 2022 | Bisker-Leib Vered | Chief Operating Officer | Sell(S) | 16K | $4.34 | $70K |
| Nov 18, 2022 | Bisker-Leib Vered | Chief Operating Officer | Sell(S) | 6K | $4.40 | $27K |
| Nov 8, 2022 | Gordon Carl L | Director, 10% Owner | Buy(P) | 402K | $3.21 | $1.3M |
| Nov 8, 2022 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 402K | $3.21 | $1.3M |
| Sep 28, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 10K | $2.32 | $23K |
| Sep 26, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 15K | $2.27 | $34K |
| Sep 7, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 15K | $3.03 | $45K |
| Sep 1, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 15K | $2.83 | $42K |
| Aug 17, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 15K | $3.05 | $46K |
| Aug 10, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 15K | $2.64 | $40K |
| Aug 1, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 15K | $2.58 | $39K |
| Jun 21, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $2.80 | $56K |
| Jun 16, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $2.34 | $47K |
| Jun 13, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 30K | $2.29 | $69K |
| Jun 6, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 30K | $2.83 | $85K |
| Jun 1, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $3.03 | $61K |
| May 26, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $3.04 | $61K |
| May 23, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 18K | $2.72 | $50K |
| May 17, 2022 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER, Director | Buy(P) | 20K | $2.47 | $50K |
| May 13, 2022 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 31K | $2.49 | $76K |
| May 13, 2022 | Gordon Carl L | Director, 10% Owner | Buy(P) | 31K | $2.49 | $76K |
| May 12, 2022 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 97K | $2.35 | $228K |
| May 12, 2022 | Gordon Carl L | Director, 10% Owner | Buy(P) | 97K | $2.35 | $228K |
| May 11, 2022 | Orbimed Advisors LLC | Director, 10% Owner | Buy(P) | 65K | $1.79 | $116K |
| May 11, 2022 | Gordon Carl L | Director, 10% Owner | Buy(P) | 65K | $1.79 | $116K |
| May 10, 2022 | Gordon Carl L | Director, 10% Owner | Buy(P) | 24K | $1.60 | $39K |
| May 10, 2022 | OrbiMed Capital GP V LLC | Director, 10% Owner | Buy(P) | 24K | $1.60 | $39K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).